3-Deoxy-2β,16-dihydroxynagilactone E, a natural compound from Podocarpus nagi, preferentially inhibits JAK2/STAT3 signaling by allosterically interacting with the regulatory domain of JAK2 and induces apoptosis of cancer cells

被引:24
作者
Shan, Hui [1 ,4 ]
Yao, Sheng [2 ,3 ,4 ]
Ye, Yang [2 ,3 ,4 ]
Yu, Qiang [1 ,4 ]
机构
[1] Chinese Acad Sci, Shanghai Inst Mat Med, Div Antitumor Pharmacol, Shanghai 201203, Peoples R China
[2] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 201203, Peoples R China
[3] Chinese Acad Sci, Shanghai Inst Mat Med, Nat Prod Chem Dept, Shanghai 201203, Peoples R China
[4] Univ Chinese Acad Sci, Beijing 100049, Peoples R China
基金
中国国家自然科学基金;
关键词
JAK/STAT; 3-deoxy-2; beta; 16-dihydroxynagilactone E; tyrosine kinase inhibitor; allosteric inhibitor; cancer; JANUS KINASE FAMILY; ACTIVATION; GROWTH; STAT3; AZD1480; ROLES; TRANSDUCER; DISCOVERY; PATHWAYS; SURVIVAL;
D O I
10.1038/s41401-019-0254-4
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The Janus kinase (JAK)/signal transducer and activator of transcription (STAT) pathways, especially the JAK2/STAT3 pathway, play vital roles in the development of many malignancies. Overactivation of STAT3 promotes cancer cell survival and proliferation. Therefore, the JAK2/STAT3-signaling pathway has been considered a promising target for cancer therapy. In this study, we identified a natural compound 3-deoxy-2 beta,16-dihydroxynagilactone E (B6) from the traditional Chinese medicinal plant Podocarpus nagi as a potent inhibitor of STAT3 signaling. B6 preferentially inhibited the phosphorylation of STAT3 by interacting with and inactivating JAK2, the main upstream kinase of STAT3. B6 dose-dependently inhibited IL-6-induced STAT3 signaling with an IC50 of 0.2 mu M. In contrast to other JAK2 inhibitors, B6 did not interact with the catalytic domain but instead with the FERM-SH2 domain of JAK2. This interaction was JAK-specific since B6 had little effect on other tyrosine kinases. Furthermore, B6 potently inhibited the growth and induced apoptosis of MDA-MB-231 and MDA-MB-468 breast cancer cells with overactivated STAT3. Taken together, our study uncovers a novel compound and a novel mechanism for the regulation of JAK2 and offers a new therapeutic approach for the treatment of cancers with overactivated JAK2/STAT3.
引用
收藏
页码:1578 / 1586
页数:9
相关论文
共 46 条
  • [1] The roles of JAK/STAT signaling in Drosophila immune responses
    Agaisse, H
    Perrimon, N
    [J]. IMMUNOLOGICAL REVIEWS, 2004, 198 : 72 - 82
  • [2] Constitutive activation of STAT3 in breast cancer cells: A review
    Banerjee, Kasturi
    Resat, Haluk
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2016, 138 (11) : 2570 - 2578
  • [3] Boudny V, 2002, NEOPLASMA, V49, P349
  • [4] "Do We Know Jack" About JAK? A Closer Look at JAK/STAT Signaling Pathway
    Bousoik, Emira
    Aliabadi, Hamidreza Montazeri
    [J]. FRONTIERS IN ONCOLOGY, 2018, 8
  • [5] JAK inhibitors in dermatology: The promise of a new drug class
    Damsky, William
    King, Brett A.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (04) : 736 - 744
  • [6] A JAK1 Selective Kinase Inhibitor and Tofacitinib Affect Macrophage Activation and Function
    De Vries, L. C. S.
    Duarte, J. M.
    de Krijger, M.
    Welting, O.
    van Harnersveld, P. H. P.
    Van Leeuwen-Hilbers, F. W. M.
    Moerland, P. D.
    Jongejan, A.
    D'Haens, G. R.
    De Jonge, W. J.
    Wildenberg, M. E.
    [J]. INFLAMMATORY BOWEL DISEASES, 2019, 25 (04) : 647 - 660
  • [7] STAT3 and apoptosis challenges in cancer
    Fathi, Nazanin
    Rashidi, Golnaz
    Khodadadi, Ali
    Shahi, Shahriar
    Sharifi, Simin
    [J]. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2018, 117 : 993 - 1001
  • [8] New podolactones from the seeds of Podocarpus nagi and their anti-inflammatory effect
    Feng, Zhe-Ling
    Zhang, Tian
    Liu, Jing-Xin
    Chen, Xiu-Ping
    Gan, Li-She
    Ye, Yang
    Lin, Li-Gen
    [J]. JOURNAL OF NATURAL MEDICINES, 2018, 72 (04) : 882 - 889
  • [9] The Janus Kinase (JAK) FERM and SH2 Domains: Bringing Specificity to JAK-Receptor Interactions
    Ferrao, Ryan
    Lupardus, Patrick J.
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2017, 8
  • [10] REGULATION OF THE JAK STAT SIGNALING PATHWAY
    FINBLOOM, DS
    LARNER, AC
    [J]. CELLULAR SIGNALLING, 1995, 7 (08) : 739 - 745